BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24587179)

  • 21. Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer.
    Verma S; Shankar E; Chan ER; Gupta S
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular interactions in the tropism of prostate cancer to bone.
    Sikes RA; Nicholson BE; Koeneman KS; Edlund NM; Bissonette EA; Bradley MJ; Thalmann GN; Cecchini MG; Pienta KJ; Chung LW
    Int J Cancer; 2004 Jul; 110(4):497-503. PubMed ID: 15122581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.
    Babcook MA; Sramkoski RM; Fujioka H; Daneshgari F; Almasan A; Shukla S; Nanavaty RR; Gupta S
    Cell Death Dis; 2014 Nov; 5(11):e1536. PubMed ID: 25412314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
    Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials].
    Zhang LL; He DL; Li X; Li L; Zhu GD; Wang XY
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):913-6. PubMed ID: 17121023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.
    Jin R; Sterling JA; Edwards JR; DeGraff DJ; Lee C; Park SI; Matusik RJ
    PLoS One; 2013; 8(4):e60983. PubMed ID: 23577181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative analysis of gene expression in normal and cancer human prostate cell lines].
    Rosenberg IeE; Herashchenko HV; Kashuba VI
    Ukr Biochem J; 2014; 86(2):119-28. PubMed ID: 24868918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
    Saraon P; Cretu D; Musrap N; Karagiannis GS; Batruch I; Drabovich AP; van der Kwast T; Mizokami A; Morrissey C; Jarvi K; Diamandis EP
    Mol Cell Proteomics; 2013 Jun; 12(6):1589-601. PubMed ID: 23443136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression.
    Oudes AJ; Roach JC; Walashek LS; Eichner LJ; True LD; Vessella RL; Liu AY
    BMC Cancer; 2005 Jul; 5():86. PubMed ID: 16042785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
    Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
    Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
    Dorai T; Dutcher JP; Dempster DW; Wiernik PH
    Prostate; 2004 Jun; 60(1):1-17. PubMed ID: 15129424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
    Meyer-Siegler K
    Mol Med; 2001 Dec; 7(12):850-60. PubMed ID: 11876163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.
    DeHaan AM; Wolters NM; Keller ET; Ignatoski KM
    Prostate; 2009 Apr; 69(5):528-37. PubMed ID: 19143022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic prostate cancer.
    Sarveswaran S; Ghosh R; Morisetty S; Ghosh J
    PLoS One; 2015; 10(4):e0122805. PubMed ID: 25875826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
    Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET
    Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies.
    Hagberg Thulin M; Jennbacken K; Damber JE; Welén K
    Clin Exp Metastasis; 2014 Mar; 31(3):269-83. PubMed ID: 24292404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptomic Analysis of LNCaP Tumor Xenograft to Elucidate the Components and Mechanisms Contributed by Tumor Environment as Targets for Dietary Prostate Cancer Prevention Studies.
    Yu L; Li RW; Huang H; Pham Q; Yu L; Wang TTY
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33808801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.